×

Integra LifeSciences to Participate in Three Investor Conferences in May

PLAINSBORO, N.J., April 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in May:

  • At 2:10PM ET on Wednesday, May 6, 2015, Glenn Coleman, Integra's Chief Financial Officer, will present at the Deutsche Bank 40th Annual Health Care Conference in Boston, Massachusetts. This presentation will be webcast.
  • At 9:20AM PT on Thursday, May 14, 2015, Mr. Coleman will present at the Bank of America Merrill Lynch 2015 Health Care Conference in Las Vegas, Nevada. This presentation will be webcast.
  • At 10:30AM ET on Monday, May 18, 2015, Mr. Coleman will present at the UBS 2015 Global Healthcare Conference in New York City. This presentation will be webcast.

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for caregivers, so they can concentrate on providing the best patient care. Integra offers innovative solutions, including leading regenerative technologies, in specialty surgical solutions, orthopedics and tissue technologies, and spine hardware and orthobiologics. For more information, please visit www.integralife.com

Statements made at the upcoming conference may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item 1A of Integra's Annual Report on Form 10-K for the year ended December 31, 2014 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Integra LifeSciences Holdings Corporation Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com

Source:Integra LifeSciences Holdings Corp.